Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joseph E. Payne currently holds 196,000 shares of Arcturus Therapeutics Holdings Inc. (ARCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph E. Payne has been a net buyer of ARCT stock. They have purchased $242.1K and sold $0 worth of shares.
Joseph E. Payne's most recent insider trade was on Dec 16, 2024, when they sold 196,000 shares at $0.00 per share.
Joseph E. Payne serves as Executive at Arcturus Therapeutics Holdings Inc. (ARCT). They have executed 6 insider transactions totaling $242.1K over their tenure at the company.
Joseph E. Payne holds the position of Executive at Arcturus Therapeutics Holdings Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Joseph E. Payne has shown a buying trading pattern, with $242.1K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Joseph E. Payne was on Nov 23, 2022, when they purchased $82.5K worth of ARCT shares. This transaction involved 5,000 shares at $16.51 per share.
Joseph E. Payne currently owns 196,000 shares of Arcturus Therapeutics Holdings Inc. (ARCT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joseph E. Payne's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joseph E. Payne has 6 Form 4 filings on record as an insider at Arcturus Therapeutics Holdings Inc..
Set alerts for Joseph E. Payne and 40,000+ other insiders.